137 related articles for article (PubMed ID: 8318407)
1. Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
Haak HR; Cornelisse CJ; Hermans J; Cobben L; Fleuren GJ
Br J Cancer; 1993 Jul; 68(1):151-5. PubMed ID: 8318407
[TBL] [Abstract][Full Text] [Related]
2. [Histology, immunocytochemistry and DNA cytophotometry of adrenocortical tumors--a clinicomorphological study of 72 tumors].
Schröder S; Padberg BC; Achilles E; Lauritzen I; Dralle H; Klöppel G
Verh Dtsch Ges Pathol; 1990; 74():284-8. PubMed ID: 1708604
[TBL] [Abstract][Full Text] [Related]
3. Cellular DNA profiles of benign and malignant adrenocortical tumors.
Cibas ES; Medeiros LJ; Weinberg DS; Gelb AB; Weiss LM
Am J Surg Pathol; 1990 Oct; 14(10):948-55. PubMed ID: 2403197
[TBL] [Abstract][Full Text] [Related]
4. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
5. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
6. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma.
Lee JE; Berger DH; el-Naggar AK; Hickey RC; Vassilopoulou-Sellin R; Gagel RF; Burgess MA; Evans DB
Surgery; 1995 Dec; 118(6):1090-8. PubMed ID: 7491528
[TBL] [Abstract][Full Text] [Related]
7. C-myc expression in adrenocortical tumours.
Pennanen M; Hagström J; Heiskanen I; Sane T; Mustonen H; Arola J; Haglund C
J Clin Pathol; 2018 Feb; 71(2):129-134. PubMed ID: 28801349
[TBL] [Abstract][Full Text] [Related]
8. [Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].
Poliakova GA; Kazantseva IA; Kalinin AP; Perov AI; Bokova EV
Arkh Patol; 1999; 61(3):30-4. PubMed ID: 10476345
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of adrenal cortical tumor DNA. Relationship between cellular DNA and histopathologic classification.
Bowlby LS; DeBault LE; Abraham SR
Cancer; 1986 Oct; 58(7):1499-505. PubMed ID: 3742468
[TBL] [Abstract][Full Text] [Related]
10. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
11. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
Lü X; Stallmach T; Gebbers JO
Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
[TBL] [Abstract][Full Text] [Related]
12. DNA quantification and ploidy patterns in human adrenocortical neoplasms.
Pignatelli D; Leitão D; Maia M; Schmidt F
Endocr Res; 1998; 24(3-4):869-74. PubMed ID: 9888590
[TBL] [Abstract][Full Text] [Related]
13. Nuclear DNA patterns in adrenal cortex proliferative lesions.
Díaz-Cano S; González-Cámpora R; Ríos-Martín JJ; Lerma-Puertas E; Jordà-Heras M; Vázquez-Ramírez F; Bibbo M; Galera-Davidson H
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):323-8. PubMed ID: 8116223
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of DNA aneuploidy in adrenal tumors].
Itakura H; Kinoshita K; Munakata A; Takamoto S; Minowada S; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):53-8. PubMed ID: 1564827
[TBL] [Abstract][Full Text] [Related]
15. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.
Hosaka Y; Rainwater LM; Grant CS; Young WF; Farrow GM; van Heerden JA; Lieber MM
Surgery; 1987 Dec; 102(6):1027-34. PubMed ID: 2446399
[TBL] [Abstract][Full Text] [Related]
17. DNA cytophotometry in adrenocortical tumours: a clinicomorphological study of 66 cases.
Padberg BC; Lauritzen I; Achilles E; Holl K; Bressel M; Klöppel G; Dralle H; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):167-70. PubMed ID: 1926757
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of nuclear DNA from adrenocortical neoplasms. A retrospective study using paraffin-embedded tissue.
Amberson JB; Vaughan ED; Gray GF; Naus GJ
Cancer; 1987 Jun; 59(12):2091-5. PubMed ID: 3567870
[TBL] [Abstract][Full Text] [Related]
19. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.
Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H
Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
Dickstein G; Shechner C; Arad E; Best LA; Nativ O
J Clin Endocrinol Metab; 1998 Sep; 83(9):3100-3. PubMed ID: 9745410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
